Cardiovascular Renal Metabolic

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine: Managing Common Co-morbidities as One

Neha Pagidipati, Carel Le Roux, Lawrence A Leiter, et al

Bariatric Surgery: Reduced CVD Risk via PREVENT Equations

Danxia Yu

Watch time: 5m 30s

Kayo Waki , Shuya Iwata , Toshimasa Yamauchi , et al

Read time: 13m 32s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s

Radcliffe CVRM

Redefining Obesity: Beyond BMI

Robert Eckel

Watch time: 13m 6s
THT 2025: The SUMMIT Trial

Barry Borlaug

Watch time: 6m 31s

Mohammed El-Sheikh , Nora Olsen El Caidi , Aginsha Kandiah , et al

Read time: 20m 9s
Medical and Procedural Options and the Referral Pathways

Harold Bays, Francesco Rubino , Alexander Miras, et al

Watch time: 1h 4m 31s

David Wheeler, Carol Pollock et al

Muthiah Vaduganathan

Sydney Tang et al

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Clara Bonanad Lozano , Anjay Rastogi

Andrew JS Coats, Stefan Anker

Tina Vilsbøll, Neha Pagidipati, Linda Mellbin et al

Watch time: 2h (19 videos)

David K Ryan , Debasish Banerjee , Fadi Jouhra

Read time: 10m
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Broadcast

Heart Failure

Prevention & Chronic Conditions
Optimising RAASi Management in Cardiorenal Patients

Andrew Frankel, Shelley Zieroth, , et al

Watch time: 1h 7m 6s

Media

Broadcast

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
KDIGO GEMs - Glomerular Diseases

Brad Rovin, Jürgen Floege, Silke Brix, et al

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s
ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Tina Vilsbøll, Neha Pagidipati, Linda Mellbin et al

Watch time: 2h (19 videos)

Media

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine: Managing Common Co-morbidities as One

Neha Pagidipati, Carel Le Roux, Lawrence A Leiter, et al

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
Bariatric Surgery: Reduced CVD Risk via PREVENT Equations

Danxia Yu

Watch time: 5m 30s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Integrating New Weight Management Therapies into Comprehensive CVD Care

Steven E Nissen

Watch time: 7m 16s
Redefining Obesity: Beyond BMI

Robert Eckel

Watch time: 13m 6s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
Optimisation of Guideline-directed Medical Therapy in Cardiorenal Patients

Ileana L Piña, David Wheeler, , et al

Watch time: 45m 39s
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
Metabolic Syndrome Management: Time-Restricted Eating

Pam Taub

Watch time: 9m 23s

Articles

Digital Therapeutics and Type 2 Diabetes

Kayo Waki

,

Shuya Iwata

,

Toshimasa Yamauchi

,

Masaomi Nangaku

,

Kazuhiko Ohe

,

Published:

10 April 2025

Citation:

Journal of Asian Pacific Society of Cardiology 2025;4:e09.

DOI:

https://doi.org/10.15420/japsc.2024.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 195
  • Downloads: Downloads 16
  • Read time: 13m 32s

The True Obesity Paradox: Obese and Malnourished?

Mohammed El-Sheikh

,

Nora Olsen El Caidi

,

Aginsha Kandiah

,

et al

Published:

19 February 2025

Citation:

Cardiac Failure Review 2025;11:e03.

DOI:

https://doi.org/10.15420/cfr.2024.35
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 542
  • Downloads: Downloads 37
  • Read time: 20m 9s

Finerenone: Will It Be a Game-changer?

Dinesh Khullar

,

Anish Kumar Gupta

,

Kulwant Singh

,

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

DOI:

https://doi.org/10.15420/cfr.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3367
  • Downloads: Downloads 210
  • Citations: 1
  • Read time: 21m 40s

Aldosterone and Potassium in Heart Failure

Laibah Arshad Khan

,

Adeena Jamil

,

Stephen J Greene

,

et al

Published:

20 December 2024

Citation:

Cardiac Failure Review 2024;10:e18.

DOI:

https://doi.org/10.15420/cfr.2024.09
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1826
  • Downloads: Downloads 181
  • Citations: 1
  • Read time: 37m 48s